other_material
confidence high
sentiment negative
materiality 0.85
Sensei Biotherapeutics discontinues solnerstotug, initiates strategic review for sale or wind-down
Sensei Biotherapeutics, Inc.
- Board discontinues development of solnerstotug after review of pipeline and market conditions.
- Initiated comprehensive review of strategic alternatives, including sale, merger, licensing, or orderly wind-down.
- Workforce reduction planned to preserve cash; details to be disclosed separately.
- Small team retained to assist with strategic review, regulatory compliance, and orderly cessation of development.